Discover the making-of the International Liver Congress 2021
We would like to thank every single participant who took part in this year's ILC, held 23–26 June 2021. The event brought together almost 6,500 delegates from over 100 countries, who took…
Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021
For Immediate Release Media Release Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021 New data released on trials involving RNAi therapeutics, antivirals and structurally engineered fatty acids to…
A highlight of ILC 2021: a triumvirate of Nobel Laureates
In EASL Studio, we were honoured to keep company with the three 2020 Nobel Laureates, awarded the 2020 Nobel Prize for Physiology and Medicine for their discovery of the hepatitis C virus.…
Advances in new drugs to for curing Hepatitis B and Hepatitis D announced at ILC 2021
For Immediate Release Media Release Advances in new drugs to for curing Hepatitis B and Hepatitis D announced at ILC 2021 Thursday 24 June 2021 (Geneva, Switzerland)-- Leading hepatology researchers announced important…
ILC 2021 opens with focus on impact of COVID-19 on global liver disease
For Immediate Release Media Release ILC 2021 opens with focus on impact of COVID-19 on global liver disease New data demonstrates that chronic liver disease increased the odds of COVID-19 death by 80% and Pfizer-BioNTech COVID-19…
Showcasing EU-funded projects at ILC 2021
Five EU-funded projects to explore at ILC 2021
2021 update on EASL Clinical Practice Guidelines on non-invasive techniques for the evaluation of liver disease and severity
Mark your calendars! On 22 of June 2021, the European Association for the Study of Liver disease (EASL) will be releasing the much-anticipated updated guidelines on the use of non-invasive techniques (NITs). These new…